Loading...
Medicover AB (publ)
MCVEY•PNK
Healthcare
Medical - Care Facilities
$16.55
$0.00(0.00%)
Medicover AB (publ) (MCVEY) Financial Performance & Income Statement Overview
Review Medicover AB (publ)’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
19.78%
↑ 19.78%
Operating Income Growth
14.50%
↑ 14.50%
Net Income Growth
-5.11%
↓ 5.11%
Operating Cash Flow Growth
27.76%
↑ 27.76%
Operating Margin
4.02%
↑ 4.02%
Gross Margin
21.94%
↑ 21.94%
Net Profit Margin
1.41%
↑ 1.41%
ROE
6.27%
↑ 6.27%
ROIC
5.42%
↑ 5.42%
Medicover AB (publ) (MCVEY) Income Statement & Financial Overview
Review Medicover AB (publ)'s (MCVEY) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $578.10M | $555.80M | $527.80M | $509.40M |
| Cost of Revenue | $445.40M | $435.10M | $414.70M | $399.50M |
| Gross Profit | $132.70M | $120.70M | $113.10M | $109.90M |
| Gross Profit Ratio | $0.23 | $0.22 | $0.21 | $0.22 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $96.70M | $97.40M | $106.40M | $88.60M |
| Operating Expenses | $96.70M | $97.40M | $106.40M | $88.60M |
| Total Costs & Expenses | $542.10M | $532.50M | $521.10M | $488.10M |
| Interest Income | $1.00M | $1.20M | $1.80M | $1.00M |
| Interest Expense | $15.20M | $15.10M | $17.30M | $14.10M |
| Depreciation & Amortization | $50.50M | $49.90M | $67.20M | $28.60M |
| EBITDA | $91.80M | $75.40M | $77.40M | $49.90M |
| EBITDA Ratio | $0.16 | $0.14 | $0.15 | $0.10 |
| Operating Income | $36.00M | $23.30M | $6.70M | $21.30M |
| Operating Income Ratio | $0.06 | $0.04 | $0.01 | $0.04 |
| Other Income/Expenses (Net) | -$9.90M | -$12.90M | -$13.80M | -$13.20M |
| Income Before Tax | $26.10M | $10.40M | -$7.10M | $8.10M |
| Income Before Tax Ratio | $0.05 | $0.02 | -$0.01 | $0.02 |
| Income Tax Expense | $7.30M | $3.00M | -$1.90M | $2.20M |
| Net Income | $20.10M | $8.60M | -$4.40M | $6.30M |
| Net Income Ratio | $0.03 | $0.02 | -$0.008 | $0.01 |
| EPS | $0.13 | $0.06 | -$0.03 | $0.04 |
| Diluted EPS | $0.13 | $0.06 | -$0.03 | $0.04 |
| Weighted Avg Shares Outstanding | $150.14M | $150.14M | $150.14M | $150.00M |
| Weighted Avg Shares Outstanding (Diluted) | $150.98M | $150.14M | $150.14M | $150.14M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan